Investigating a lipid kinase's role in chronic lymphocytic leukemia

Pro-Oncogenic Role of a Mitochondrial Lipid Kinase in CLL

NIH-funded research University of Oklahoma Hlth Sciences Ctr · NIH-10825589

This study is looking at a protein called acylglycerol kinase (AGK) that is found in higher amounts in some people with chronic lymphocytic leukemia (CLL), to see how it affects the disease and could help find better treatments for patients like you.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Oklahoma Hlth Sciences Ctr NIH-funded
Lab location1 site (Oklahoma City, United States)
Project IDNIH-10825589 on NIH RePORTER

What this research studies

This research focuses on chronic lymphocytic leukemia (CLL), a type of cancer affecting B-cells. It aims to understand the role of a specific mitochondrial lipid kinase, acylglycerol kinase (AGK), which has been found to be highly expressed in many CLL patients. By exploring how AGK contributes to the development and resistance of CLL, the research seeks to uncover new insights into the disease's biology. This could lead to improved treatment strategies for patients suffering from CLL.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults diagnosed with chronic lymphocytic leukemia, particularly those who have not yet received therapy.

Not a fit: Patients with other types of leukemia or those who have already undergone extensive treatment for CLL may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic targets for treating chronic lymphocytic leukemia more effectively.

How similar studies have performed: Other research has shown promising results in targeting similar oncogenic pathways in various cancers, indicating potential for success in this area as well.

Where this research is happening

Oklahoma City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.